Testing new potential drug with chemotherapy for young leukemia patients

Waiting for recruting

Select region:

Navigation:

    What is this study about?

    This is a study of a medicine called JNJ-75276617 when it is combined with usual chemotherapy treatment to help children and young adults battling difficult cases of acute leukemia. The researchers are testing varying doses of the new medicine in the first phase of the study to find the one that is most beneficial and safe when used with regular chemotherapy. The researchers will then use the preferred dose achieved from the first phase to continue testing in the second phase. Scientists are focused on safety and understanding any side-effects that might happen during the trial. These might range from mild discomfort to severe reactions. This trial will also check how the new medicine affects the number and development of dangerous leukemia cells. Researchers are also interested understanding how the new drug affects certain genes that contribute to leukemia.

    Learn more about this Trial

      I accept the Terms of Use and Privacy Policy*

       I consent to the Service Operator sending commercial information*

      I consent to the Service Operator using telecommunications terminal devices and automatic calling systems in marketing communications*

      Success

      Your form submitted successfully!

      Error

      Sorry! your form was not submitted properly, Please check the errors above.

      Locations

      Where does the clinical trial take place?

      You can join this study in:

      Study Steps

      How Complex Will My Study Be and What Phases Will I Go Through?


      Diseases Under Investigation

      What Conditions Qualify Me for This Study?


      Terms and conditions

      What Requirements I Have to Meet To Join This Study?

      When Am I Eligible to Join the Study?

      What Reasons Could Exclude Me from the Study?


      Investigational Medicinal Product

      What Products Are Being Used in This Study?

      Have the Medicinal Substances Used in the Trial Been Previously Studied in Medicine?


      Study ID

      CT-EU-00091714

      Recruitment status

      Waiting for recruting

      Start of the trial

      3 weeks ago